Summary
For Year 2026-27, Indoco Remedies reports the following shareholding: Total Promoters at 58.9%, Mutual Fund at 17.55%, Insurance at 0%, Foreign Institutional Investors at 1.1%, Domestic Institutional Investors at 0.6%, and Retail at 21.86%. This breakdown provides a quick snapshot of ownership distribution for Indoco Remedies in 2026-27.
Indoco Remedies FAQs
As of 04-2026, the promoter shareholding in Indoco Remedies stands at 58.9% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Indoco Remedies is 1.1% and 0.6% respectively.
The retail shareholding of the Indoco Remedies is 21.86%.
Changes in shareholding patterns of Indoco Remedies can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Indoco Remedies are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
